| PERIOD ENDING | 30-Sep-08 | 30-Jun-08 | 31-Mar-08 | 31-Dec-07 | | Total Revenue | 2,497,800 | 2,658,200 | 2,500,700 | 2,564,500 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 2,497,800 | 2,658,200 | 2,500,700 | 2,564,500 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 2,401,700 | 2,452,200 | 2,288,700 | 2,594,500 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 96,100 | 206,000 | 212,000 | (30,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 96,100 | 206,000 | 212,000 | (30,000) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 96,100 | 206,000 | 212,000 | (30,000) | | Income Tax Expense | (2,200) | 29,400 | 29,600 | (52,200) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 98,300 | 176,600 | 182,400 | 22,200 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| 20,200 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 98,300 | 176,600 | 182,400 | 42,400 | | Preferred Stock And Other Adjustments | (8,200) | (8,300) | (8,200) | (8,300) | | | Net Income Applicable To Common Shares | $90,100 | $168,300 | $174,200 | $34,100 |
|
2.05% Nasdaq 
Income Statement
